Correlation Between Kiromic Biopharma and Nuvation Bio
Can any of the company-specific risk be diversified away by investing in both Kiromic Biopharma and Nuvation Bio at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Kiromic Biopharma and Nuvation Bio into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Kiromic Biopharma and Nuvation Bio, you can compare the effects of market volatilities on Kiromic Biopharma and Nuvation Bio and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Kiromic Biopharma with a short position of Nuvation Bio. Check out your portfolio center. Please also check ongoing floating volatility patterns of Kiromic Biopharma and Nuvation Bio.
Diversification Opportunities for Kiromic Biopharma and Nuvation Bio
0.27 | Correlation Coefficient |
Modest diversification
The 3 months correlation between Kiromic and Nuvation is 0.27. Overlapping area represents the amount of risk that can be diversified away by holding Kiromic Biopharma and Nuvation Bio in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Nuvation Bio and Kiromic Biopharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Kiromic Biopharma are associated (or correlated) with Nuvation Bio. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Nuvation Bio has no effect on the direction of Kiromic Biopharma i.e., Kiromic Biopharma and Nuvation Bio go up and down completely randomly.
Pair Corralation between Kiromic Biopharma and Nuvation Bio
If you would invest 318.00 in Nuvation Bio on September 3, 2024 and sell it today you would lose (28.00) from holding Nuvation Bio or give up 8.81% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 0.68% |
| Values | Daily Returns |
Kiromic Biopharma vs. Nuvation Bio
Performance |
| Timeline |
| Kiromic Biopharma |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
| Nuvation Bio |
Kiromic Biopharma and Nuvation Bio Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Kiromic Biopharma and Nuvation Bio
The main advantage of trading using opposite Kiromic Biopharma and Nuvation Bio positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Kiromic Biopharma position performs unexpectedly, Nuvation Bio can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Nuvation Bio will offset losses from the drop in Nuvation Bio's long position.| Kiromic Biopharma vs. Quoin Pharmaceuticals Ltd | Kiromic Biopharma vs. Allarity Therapeutics | Kiromic Biopharma vs. Virax Biolabs Group | Kiromic Biopharma vs. Biodexa Pharmaceticals |
| Nuvation Bio vs. DiaMedica Therapeutics | Nuvation Bio vs. Lyra Therapeutics | Nuvation Bio vs. Centessa Pharmaceuticals PLC |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Comparator module to compare the composition, asset allocations and performance of any two portfolios in your account.
Other Complementary Tools
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years |